Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
171.00    0.60 (0.35%)
Bid:
179.00
Ask:
160.80
Spread: -18.20 (-10.168%)
Market Cap: £209.84m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Director Declaration

19 Jun 2025 14:30

RNS Number : 6276N
SThree plc
19 June 2025
 

19 June 2025

 

 

SThree plc

 

(the "Company")

 

Appointment of Senior Independent Director and changes in Directors' Responsibilities

 

As previously announced on 24 January 2025, having served as a non-executive director for nineyears, Denise Collis will be retiring from the Board on 30 June 2025.

In accordance with UKLR 6.4.6, SThree plc, the global STEM workforce consultancy, todayannounces that, with effect from 1 July 2025, Imogen Joss, who was appointed to the Board in December 2022, will become Senior Independent Director and Chair of the Remuneration Committee and Sanjeevan Bala, who was appointed to the Board in April 2024, will become Employee Engagement NED.

James Bilefield, Chair, said:

"I am immensely grateful to Denise for her significant contribution and dedication since her appointment. In addition to successfully discharging her responsibilities as our Senior Independent Director and Remuneration Committee Chair, Denise fully embraced the role of being our first Employee Engagement NED and has been a champion of and mentor to many of our colleagues in the business. I look forward to working with Imogen and Sanjeevan in their new roles."

 

 

Enquiries:

 

 

 

SThree plc

Timo Lehne, CEO

Andrew Beach, CFO

Keren Oser, Investor Relations Director

 

 

 via Alma

Alma Strategic Communications

+44 20 3405 0205

 

Rebecca Sanders-Hewett

Hilary Buchanan

Sam Modlin

Will Ellis Hancock

SThree@almastrategic.com

 

 

 

Notes to editors

SThree plc brings skilled people together to build the future. We are the global STEM workforce consultancy, placing highly skilled, STEM specialist workers in the industries where they are needed most. We advise businesses, build expert teams, and deliver project solutions for our clients. With more than 38 years of experience in pure-play STEM and a global team with local expertise across 11 countries, we cover high-demand skills across Engineering, Life Sciences and Technology roles.

 

We provide permanent and flexible contract talent to a diverse base of around 6,000 clients. By combining advanced technology with expertise, we push beyond traditional boundaries to deliver tailored solutions, leveraging data and insight from our world-class operating platform.

 

Outpace tomorrow, together

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNFLMJTMTMBBRA
Date   Source Headline
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSFY25 Q1 Trading Update
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20253:45 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20253:00 pmRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20254:45 pmRNSDirector/PDMR Shareholding
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 202512:30 pmRNSAnnual Financial Report
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20259:55 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 202510:51 amRNSDirector/PDMR Shareholding
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20254:01 pmRNSBlock listing Interim Review
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 202510:35 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20254:36 pmRNSHolding(s) in Company
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.